Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 31 entries
View as:

Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients

Phase: N/A Priority: Normal
NCT ID: NCT00165750 Org: User:
Start: 03/31/05 End: 11/30/08 Due: 11/30/09

A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT06625242 Org: User:
Start: 10/22/24 End: 10/27/25 Due: 10/27/26

Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization

Phase: N/A Priority: Normal
NCT ID: NCT02726074 Org: User:
Start: 05/03/16 End: 04/26/18 Due: 04/26/19

A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures

Phase: N/A Priority: Normal
NCT ID: NCT05533814 Org: User:
Start: 10/19/22 End: 01/23/25 Due: 01/23/26

Low and High Dose Zonisamide in Children as Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01127165 Org: User:
Start: 03/31/06 End: 07/31/09 Due: 07/31/10

A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants

Phase: N/A Priority: Normal
NCT ID: NCT03437083 Org: User:
Start: 01/25/18 End: 06/30/18 Due: 06/30/19

A Study of Fycompa (Perampanel) in Korean Participants

Phase: N/A Priority: Normal
NCT ID: NCT02722590 Org: User:
Start: 07/01/16 End: 06/30/21 Due: 06/30/22

Symbenda Post-Marketing Surveillance (PMS)

Phase: N/A Priority: Normal
NCT ID: NCT02434484 Org: User:
Start: 07/04/18 End: 03/20/20 Due: 03/20/21

Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01961544 Org: User:
Start: 06/30/13 End: 07/31/15 Due: 07/31/16

A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants

Phase: N/A Priority: Normal
NCT ID: NCT05225207 Org: User:
Start: 05/28/19 End: 01/31/22 Due: 01/31/23

Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02097056 Org: User:
Start: 02/28/14 End: 05/31/15 Due: 05/31/16

A Study to Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World Setting

Phase: N/A Priority: Normal
NCT ID: NCT03448445 Org: User:
Start: 06/22/18 End: 08/10/21 Due: 08/10/22

Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus ANti-TNF Versus cDMARDs in Real World

Phase: N/A Priority: Normal
NCT ID: NCT03264703 Org: User:
Start: 09/11/17 End: 07/17/19 Due: 07/17/20

Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients

Phase: N/A Priority: Normal
NCT ID: NCT03264690 Org: User:
Start: 09/21/17 End: 01/16/20 Due: 01/16/21

A Post Marketing Surveillance Study of Equfina Tablet 50 Milligram (mg)

Phase: N/A Priority: Normal
NCT ID: NCT05225324 Org: User:
Start: 06/03/21 End: 03/20/25 Due: 03/20/26

Alzheimer's Disease Long-term Follow-up Study (ALF Study)

Phase: N/A Priority: Normal
NCT ID: NCT00165724 Org: User:
Start: 06/30/04 End: 12/31/06 Due: 12/31/07

A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT06964113 Org: User:
Start: 06/30/25 End: 11/30/27 Due: 11/30/28

A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)

Phase: N/A Priority: Normal
NCT ID: NCT02262975 Org: User:
Start: 07/31/14 End: 08/31/16 Due: 08/31/17

A Study for Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT05366036 Org: User:
Start: 06/14/17 End: 01/14/22 Due: 01/14/23

A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT05208268 Org: User:
Start: 07/23/20 End: 09/22/22 Due: 09/22/23

A Postmarketing Study of Lecanemab in South Korean Participants With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06810960 Org: User:
Start: 02/24/25 End: 12/31/29 Due: 12/31/30

A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients

Phase: N/A Priority: Normal
NCT ID: NCT05375136 Org: User:
Start: 06/25/21 End: 11/07/23 Due: 11/07/24

A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies

Phase: N/A Priority: Normal
NCT ID: NCT00154076 Org: User:
Start: 09/30/05 End: 12/31/08 Due: 12/31/09

A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants

Phase: N/A Priority: Normal
NCT ID: NCT06246123 Org: User:
Start: 02/27/24 End: 07/30/27 Due: 07/30/28

Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT01140867 Org: User:
Start: 02/29/08 End: 03/31/11 Due: 03/31/12